Prevalence of ctDNA in early screen-detected breast cancers using highly sensitive and specific dual molecular barcoded personalised mutation assays

Ann Oncol. 2021 Aug;32(8):1057-1060. doi: 10.1016/j.annonc.2021.04.018. Epub 2021 Apr 29.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics
  • Breast Neoplasms* / diagnosis
  • Breast Neoplasms* / epidemiology
  • Breast Neoplasms* / genetics
  • Circulating Tumor DNA* / genetics
  • Female
  • Humans
  • Mutation
  • Prevalence

Substances

  • Biomarkers, Tumor
  • Circulating Tumor DNA